BN Business News
Add your company to Business Communicator →

Energy & environment · 18/06/2003Updated: 10/17/2026 · 1 min read

Aventis Pharmaceuticals Receives Environmental Clearance for Materials License Amendment

Summary

Aventis Pharmaceuticals, Inc. has received a finding of no significant impact and made its environmental assessment available for the license amendment of materials license number 29-15354-01, located in East Millstone, New Jersey.

Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →

Explore insights

Business insights →